drugset / Trial / NCT00625703
Pharmacokinetics of Linezolid in Children With Cystic Fibrosis
Phase 2
Completed
45 enrolled
University of Texas Southwestern Medical Center
Cystic Fibrosis Foundation · collab
NaSingle-groupOpen-labelOther
Summary
To determine the pharmacokinetic profile of IV (intravenous) and PO (oral) formulations of linezolid among children with cystic fibrosis and establish a dose regimen that will be safe and effective.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linezolid | Other / unclassified | 15 mg/kg | Intravenous |